• Duan D, Li Z, Luo H. Antiviral compounds from traditional Chinese medicines Galla Chinese as inhibitors of HCV NS3 protease[J]. Bioorg Med Chem Lett, 2004, 20;14(24): 6041-6044.

  • EL-Mekkawy S, Meselhy M R, Kusumoto I T, et al. 1995. Inhibitory effects of Egyptian folk medicines on human immunodeficiency virus (HIV) reverse trans-criptase. Chem Pharm Bull (Tokyo), 43 (4): 641-648.

  • Fukuchi K, Sakagami H, Okuda T. Inhibition of herpes simplex virus infection by tannins and related compounds[J]. Antiviral Res, 1989, 11(5-6): 285-297. doi: 10.1016/0166-3542(89)90038-7

  • Korba B E, Milman G. A cell culture assay for compounds which inhibit hepatitis B virus replication[J]. Antiviral Res, 1991, 15(3): 217-228. doi: 10.1016/0166-3542(91)90068-3

  • Lan on A, Delmas D, Osman H. Human hepatic cell uptake of resveratrol: involvement of both passive diffusion and carrier-mediated process[J]. Biochem Biophys Res Commun, 2004, 316(4): 1132-1137. doi: 10.1016/j.bbrc.2004.02.164

  • Lan on A, Hanet N, Jannin B, et al. Resveratrol in human hepatoma HepG2 cells: metabolism and inducibility of detoxifying enzymes. Drug Metab Dispos, 35 (5): 699-703.

  • Lee WM. Hepatitis B virus infection[J]. N Engl J Med, 1997, 337(24): 1733-1745. doi: 10.1056/NEJM199712113372406

  • Lee S J, Lee H K, Jung M K. In vitro antiviral activity of 1, 2, 3, 4, 6-penta-O-galloyl-beta-D-glucose against hepatitis B virus[J]. Biol Pharm Bull, 2006, 29(10): 2131-2134. doi: 10.1248/bpb.29.2131

  • Manabu T, Masayuki T, Yasuo T. 1985. Studies on antiviral activity of several hydrolyzable tannins. International congress series (Herpes viruses virus chemother), 667: 223-224.

  • Nakashima H, Ichiyama K, Hirayama F. Sulfated pentagalloyl glucose (Y-ART-3) inhibits HIV replication and cytopathic effects in vitro, and reduces HIV infection in hu-PBL-SCID mice[J]. Antiviral Res, 1996, 30(2-3): 95-108. doi: 10.1016/0166-3542(95)00903-5

  • Sun J, Hou J L. Management of chronic hepatitis B: experience from China[J]. J Viral Hepatitis, 2010, 17(S1): 10-17.

  • Tiollais P, Pourcel C, Dejean A. The hepatitis B virus[J]. Nature, 1985, 317(5): 489-495.

  • Xia Q, Xiao P G, Wang L W. Ethnopharmacology of Phyllanthus emblica L[J]. China J Chin Mat Med, 1997, 22(9): 515-518.

  • Xiang Y F, Pei Y, Wang Y F. Current status of natural products from plants as anti-herpes simplex virus 1 agents[J]. Virol Sin, 2008, 23(5): 305-314. doi: 10.1007/s12250-008-2962-7

  • Yeo S J, Yun Y J, Lyu M A. Respiratory syncytial virus infection induces matrix metal-loproteinase-9 expression in epithelial cells[J]. Arch Virol, 2002, 147(2): 229-242. doi: 10.1007/s705-002-8316-1

  • Zhang J, Li L, Kim S H. Anti-cancer, anti-diabetic and other pharmacologic and biological activities of penta-galloyl-glucose[J]. Pharm Res, 2009, 26(9): 2066-2080. doi: 10.1007/s11095-009-9932-0

  • Zhang L, Wang G, Hou W. Contemporary clinical research of traditional Chinese medicines for chronic hepatitis B in China: an analytical review[J]. Hepatology, 2010, 51(2): 690-698. doi: 10.1002/hep.23384

  • Zhang Y J, Abe T, Tanaka T. Phy-llanemblinins A-F, new ellagitannins from Phyllanthus emblica[J]. J Nat Prod, 2001, 64(12): 1527-1532. doi: 10.1021/np010370g